2,688 results on '"silybin"'
Search Results
2. Novel insights into acetylation kinetics in a continuous Flow milli-reactor for chemo-enzymatic separation of silybin A/B.
- Author
-
Fortunato, Michele Emanuele, Pagano, Rita, Romanucci, Valeria, Licenziato, Chiara, Zarrelli, Armando, Di Serio, Martino, Di Fabio, Giovanni, and Russo, Vincenzo
- Subjects
- *
NONLINEAR regression , *FLOW chemistry , *CHEMICAL properties , *HIGH performance liquid chromatography , *ACTIVATION energy - Abstract
The separation of silybin A (SilA) and B (SilB) diastereomers in optically pure compounds is challenging due to their very similar physical and chemical properties. However, such separation is crucial for evaluating the biological activity of the diasteroisomers SilA and SilB, which show very different performance in pharmacological applications like treating prostate cancer, liver diseases, and Alzheimer's disease. The most common isolation method is based on high-performance liquid chromatography, but it is slow and has a yield in pure SilB of hundreds of milligrams per day. An alternative chemo-enzymatic separation method, utilizing an immobilized lipase CALB catalyst to stereoselectively acetylate silybin B (1b), offers advantages in terms of higher productivity, selectivity, and scalability, particularly when applied in flow reactors. This study delves into the kinetics of Sil acetylation catalyzed by Novozym 435 in a continuous flow milli-reactor, investigated at various temperatures, volumetric flow rates, and Sil initial concentrations. It is noteworthy that, at the current state of the art, there is a lack of kinetic studies on this reaction, emphasizing the novelty and significance of this work. The kinetic and fluid dynamic parameters were estimated using a non-linear regression analysis of experimental data. The examined reaction showed a null apparent activation energy, explaining the temperature insensitivity of the final acetylated silybin B (1b) concentration. Furthermore, the decrease in steady-state concentrations of the acetylated products with increasing volumetric flow rates indicated that the reaction was occurring in a kinetic regime. Interestingly, a maximum starting Sil concentration was identified, above which there was no favorable impact on conversion. Highlights: Silybin B was more selectively acetylated compared to silybin A. Reaction rate was insensitive to temperature due to exothermic adsorption. Kinetics and adsorption parameters were obtained by non-linear regression analysis. Good prediction achieved with axial dispersion model and Eley-Rideal mechanism. Flow chemistry boosts silibinin enzymatic resolution over traditional methods. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Silybin-Functionalized PCL Electrospun Fibrous Membranes for Potential Pharmaceutical and Biomedical Applications.
- Author
-
Spartali, Christina, Psarra, Anna-Maria G., Marras, Sotirios I., Tsioptsias, Costas, Georgantopoulos, Achilleas, Kalousi, Foteini D., Tsakalof, Andreas, and Tsivintzelis, Ioannis
- Subjects
- *
DIFFERENTIAL scanning calorimetry , *COMPOSITE membranes (Chemistry) , *FIBROUS composites , *SCANNING electron microscopy , *THERMOGRAVIMETRY - Abstract
Silybin is a natural flavonolignan with potential anticancer, antioxidant, and hepatoprotective properties. In the present study, various loadings of silybin (1, 3, and 5 wt%) were encapsulated in poly-ε-caprolactone (PCL) fibers by electrospinning, in order to produce new pharmaceutical composites with improved bioactive and drug delivery properties. The morphological characteristics of the composite fibrous structures were evaluated by scanning electron microscopy (SEM), and the encapsulation efficiency and the release rate of silybin were quantified using a UV-Vis spectrophotometer. The analysis of the membranes' thermal behavior by differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA) revealed the existence of interaction between PCL and silybin. An investigation of the cytocompatibility of the composite membranes revealed that normal cells displayed an unimpeded proliferation in the respective silybin concentrations; however, tumor cell growth demonstrated a dose-dependent inhibition. Furthermore, an effective antioxidant activity against hydrogen peroxide-induced oxidative stress in HEK-293 cells was observed for the prepared electrospun fibrous mats. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Nanocrystal Formulation to Enhance Oral Absorption of Silybin: Preparation, In Vitro Evaluations, and Pharmacokinetic Evaluations in Rats and Healthy Human Subjects.
- Author
-
Seo, SeungRee, Kim, Gwan-Young, Kim, Min-Hwan, Lee, Kyung Won, Kim, Min-Jae, Chaudhary, Mansingh, Bikram, Khadka, Kim, Taeheon, Choi, Seungmok, Yang, Heejin, Park, Joo Won, Kim, Dae-Duk, and Kim, Ki-Taek
- Subjects
- *
MILK thistle , *SURFACE morphology , *IN vivo studies , *BIOAVAILABILITY , *RAW materials - Abstract
Despite the various therapeutic benefits and high tolerance of orally administered silybin, poor water-solubility can be the main restrictive physicochemical feature, which results in low oral bioavailability in the absorption. A milk thistle nanocrystal formulation (HM40) was prepared using a modified wet-milling method. Comprehensive characterization was performed to determine the physical morphology, crystallinity, and physicochemical properties. The long-term stability was evaluated over 24 months. In vitro silybin release was assessed at pH 1.2 for 2 h, followed by pH 6.8 for 4 h. Finally, in vivo pharmacokinetic studies were conducted in rats and healthy human volunteers. HM40 exhibited a nanocrystal structure maintaining crystallinity and enhanced the solubility and dissolution of silybin compared to that of the raw material. The stability over 24 months revealed consistent surface morphology, particle size, silybin content, and solubility. In vitro release profiles indicated a significant increase in the silybin release from HM40. In vivo pharmacokinetic studies demonstrated that HM40 showed 2.61- and 1.51-fold higher oral bioavailability in rats and humans, respectively, than that of the reference capsule. HM40 formulation presents a stable and promising approach for the oral delivery of poorly water-soluble silybin, with the potential for use in pharmaceutical formulations containing milk thistle. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Development, Optimization, and in vitro Evaluation of Silybin-loaded PLGA Nanoparticles and Decoration with 5TR1 Aptamer for Targeted Delivery to Colorectal Cancer Cells.
- Author
-
Rahimnia, Seyyed Mobin, Saeedi, Majid, Akbari, Jafar, Morteza-Semnani, Katayoun, Hedayatizadeh-Omran, Akbar, and Yazdian-Robati, Rezvan
- Abstract
Chemotherapeutic agents often lack specificity, intratumoral accumulation, and face drug resistance. Targeted drug delivery systems based on nanoparticles (NPs) mitigate these issues. Poly (lactic-co-glycolic acid) (PLGA) is a well-studied polymer, commonly modified with aptamers (Apts) for cancer diagnosis and therapy. In this study, silybin (SBN), a natural agent with established anticancer properties, was encapsulated into PLGA NPs to control delivery and improve its poor solubility. The field-emission scanning electron microscopy (FE-SEM) showed spherical and uniform morphology of optimum SBN-PLGA NPs with 138.57±1.30nm diameter, 0.202±0.004 polydispersity index (PDI), -16.93±0.45mV zeta potential (ZP), and 70.19±1.63% entrapment efficiency (EE). The results of attenuated total reflectance-Fourier transform infrared (ATR-FTIR) showed no chemical interaction between formulation components, and differential scanning calorimetry (DSC) thermograms confirmed efficient SBN entrapment in the carrier. Then, the optimum formulation was functionalized with 5TR1 Apt for active targeted delivery of SBN to colorectal cancer (CRC) cells in vitro. The SBN-PLGA-5TR1 nanocomplex released SBN at a sustained and constant rate (zero-order kinetic), favoring passive delivery to acidic CRC environments. The MTT assay demonstrated the highest cytotoxicity of the SBN-PLGA-5TR1 nanocomplex in C26 and HT29 cells and no significant cytotoxicity in normal cells. Apoptosis analysis supported these results, showing early apoptosis induction with SBN-PLGA-5TR1 nanocomplex which indicated this agent could cause programmed death more than necrosis. This study presents the first targeted delivery of SBN to cancer cells using Apts. The SBN-PLGA-5TR1 nanocomplex effectively targeted and suppressed CRC cell proliferation, providing valuable insights into CRC treatment without harmful effects on healthy tissues. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Silybin attenuates avermectin-induced oxidative damage in carp respiration by modulating the cGAS-STING pathway and endoplasmic reticulum stress.
- Author
-
Ping, Kaixin, Xia, Yan, Jin, Xiaohui, Xiang, Yannan, Yang, Haitao, Pan, Enzhuang, Ji, Guangquan, and Dong, Jingquan
- Abstract
Avermectin is a commonly used insect repellent for aquaculture and crops, but it is easy to remain in the aquatic environment, causing organism disorders, inflammation, and even death. This resulted in significant economic losses to the carp aquaculture industry. Silybin has antioxidant, anti-inflammatory, and anti-apoptotic properties. However, it is unclear whether Silybin counteracts gill damage caused by avermectin exposure. Therefore, we modeled avermectin exposure and Silybin intervention by adding 2.404 μg/L avermectin to water and 400 mg/kg of Silybin to feed. Gill tissue was collected and analyzed in depth during a 30-day experimental period. The results showed that avermectin exposure induced structural disorganization of gill filaments and led to increased reactive oxygen species, inhibition of antioxidant functions, induction of inflammatory responses, and endoplasmic reticulum stress in addition to the endogenous apoptotic pathway. In contrast, Silybin effectively alleviated pathological changes and reduced reactive oxygen species levels, thereby attenuating oxidative stress and endogenous apoptosis and inhibiting endoplasmic reticulum stress pathways. In addition, Silybin reduced avermectin-induced gill tissue inflammation in carp, and it is considered that it might modulate the cGAS-STING pathway. In summary, Silybin alleviates avermectin-induced oxidative damage within the carp's respiratory system by modulating the cGAS-STING pathway and endoplasmic reticulum stress. The main goal is to understand how Silybin reduces oxidative damage caused by avermectin in carp gills, offering management strategies. Concurrently, the current study proposes that Silybin can serve as a dietary supplement to reduce the risks brought on by repellent buildup in freshwater aquaculture. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Syndrome phalloïdien : mise au point.
- Author
-
Caré, W., Bruneau, C., Rapior, S., Langrand, J., Le Roux, G., and Vodovar, D.
- Abstract
Le syndrome phalloïdien est le toxidrome mycotoxique survenant après l'ingestion de certaines espèces de macromycètes, des genres Amanita , Lepiota et Galerina. Amanita phalloides est l'espèce la plus souvent en cause, responsable de plus de 90 % des décès dus à la consommation de champignons. L'α-amanitine est responsable de la plupart des effets observés. La présentation clinique est caractérisée par un tableau digestif sévère et de survenue tardive (plus de six heures après l'ingestion). Le foie étant le principal organe cible, l'évolution est marquée par une hépatite aiguë souvent sévère pouvant évoluer vers l'insuffisance hépatique terminale justifiant le recours à la transplantation hépatique orthotopique. Une insuffisance rénale aiguë est souvent observée. Le diagnostic de syndrome phalloïdien repose avant tout sur les données cliniques ; il peut être confirmé biologiquement par la mise en évidence des amatoxines, notamment sur prélèvement urinaire. En l'absence d'antidote, la prise en charge hospitalière précoce est indispensable. Elle repose sur la compensation précoce des pertes hydroélectrolytiques, la décontamination digestive, des traitements épurateurs, et des traitements médicamenteux. La thérapie combinée associant silibinine et N-acétylcystéine est recommandée afin de limiter le transport intra-hépatocytaire des amatoxines et à visée hépatoprotectrice. Le pronostic de cette intoxication grave a grandement profité de l'amélioration des techniques de réanimation. La létalité en France est actuellement inférieure à 10 %. Lors d'un cas suspecté ou avéré, le recours à un centre antipoison est recommandé, afin de pouvoir asseoir le diagnostic et guider la prise en charge médicale des patients de façon précoce et adaptée. Amatoxin-containing mushroom poisoning occurs after consumption of certain mushroom species, of the genera Amanita , Lepiota and Galerina. Amanita phalloides is the most implicated species, responsible for over more than 90% of mushroom-related deaths. The α-amanitin is responsible for most of the observed effects. Symptoms are characterized by severe delayed gastrointestinal disorders (more than six hours after ingestion). The liver being the main target organ, outcome is marked by an often severe hepatitis which can evolve towards terminal liver failure, justifying orthotopic liver transplantation. Acute renal failure is common. Diagnosis of amatoxin-containing mushroom poisoning is based primarily on clinical data; it can be biologically confirmed using detection of amatoxins, especially from urine samples. In the absence of an antidote, early hospital management is essential. It is based on supportive care (early compensation of hydroelectrolytic losses), gastrointestinal digestive decontamination, elimination enhancement, amatoxin uptake inhibitors and antioxidant therapy. Combined therapy associating silibinin and N-acetylcysteine is recommended. Prognosis of this severe poisoning has greatly benefited from improved resuscitation techniques. Mortality is currently less than 10%. In the event of a suspected or confirmed case, referral to a Poison Control Center is warranted in order to establish the diagnosis and guide the medical management of patients in an early and appropriate way. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET) (SILMET)
- Author
-
Alessia Pellerino, M.D., Ph.D.
- Published
- 2023
9. Biomimetic "nano-spears" for CAFs-targeting: splintered three "shields" with enhanced cisplatin anti-TNBC efficiency.
- Author
-
Wu, Yufan, Chen, Rujing, Ni, Shuting, and Hu, Kaili
- Subjects
- *
BIOMIMETIC materials , *CISPLATIN , *IMMUNOCOMPETENT cells , *TRIPLE-negative breast cancer , *ERYTHROCYTES , *CANCER invasiveness - Abstract
The treatment dilemma of triple-negative breast cancer (TNBC) revolves around drug resistance and metastasis. Cancer-associated fibroblasts (CAFs) contribute to cisplatin (Cis) resistance and further metastasis in TNBC, making TNBC a difficult-to-treat disease. The dense stromal barrier which restricts drug delivery, invasive phenotype of tumor cells, and immunosuppressive tumor microenvironment (TME) induced by CAFs serve as three "shields" for TNBC against Cis therapy. Here, we designed a silybin-loaded biomimetic nanoparticle coated with anisamide-modified red blood cell membrane (ARm@SNP) as a "nanospear" for CAFs-targeting, which could shatter the "shields" and significantly exhibit inhibitory effect on 4T1 cells in combination with Cis both in vitro and in vivo. The ARm@SNP/Cis elicited 4T1 tumor growth arrest and destroyed three "shields" as follows: disintegrating the stromal barrier by inhibiting blood vessels growth and the expression of fibronectin; decreasing 4T1 cell invasion and metastasis by affecting the TGF-β/Twist/EMT pathway which impeded EMT activation; reversing the immunosuppressive microenvironment by increasing the activity and infiltration of immunocompetent cells. Based on CAFs-targeting, ARm@SNP reversed the resistance of Cis, remodeled the TME and inhibited invasion and metastasis while significantly improving the therapeutic effect of Cis on 4T1 tumor-bearing mice, providing a promising approach for treating intractable TNBC. [Display omitted] • The CAFs induce three "shields" which affect TNBC against Cis therapy. • ARm@SNP, a silybin-loaded nanoparticle, was developed to target CAFs. • ARm@SNP/Cis disintegrated the stromal barrier caused by CAFs. • ARm@SNP/Cis inhibited 4T1 tumor progression through inhibiting the EMT process. • ARm@SNP/Cis reversed the immunosuppressive tumor microenvironment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Preparation and characterisation of silybin nanoemulsions based on complex emulsifiers: stability, in vitro release properties and antioxidant capacity.
- Author
-
Li, Zhibei, Liu, Xing, Liu, Kai, Zhao, Bolin, Li, Qiuxia, Xi, Jingjing, and Li, Xiaofang
- Abstract
Summary: The low solubility of Silybin (Slb) presents a significant obstacle to its further application. In this study, silybin nanoemulsion (Slb‐NE) stabilised by sodium aseinate/glycyrrhetinic acid (NaCas/GA) complex emulsifiers were prepared for effective delivery of Slb. When the NaCas:GA mass ratio was 1:1, Slb‐NE had small particle size (189 nm), low PDI (0.125), and high zeta potential (−27.27 mv). SEM, TEM, and FI‐IR studies indicated that the emulsion system was spherical and homogeneous, and Slb was successfully loaded into Slb‐NE without generating new chemical bonds. Furthermore, the complex emulsifiers improved the stability of Slb‐NE. In vitro release and antioxidant experiments showed that the incorporation of GA strengthened the sustained release and antioxidant capacity of Slb‐NE. NaCas/GA can be used as a natural and green complex emulsifiers for delivery of difficult‐to‐solve ingredients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Evaluation of Silybin Nanoparticles against Liver Damage in Murine Schistosomiasis mansoni Infection.
- Author
-
Vanzan, Daniel Figueiredo, Goma, Ester Puna, Locatelli, Fernanda Resende, Honorio, Thiago da Silva, Furtado, Priscila de Souza, Rodrigues, Carlos Rangel, de Sousa, Valeria Pereira, Mata dos Santos, Hilton Antônio, do Carmo, Flávia Almada, Simon, Alice, Pyrrho, Alexandre dos Santos, Ribeiro, António José, and Cabral, Lucio Mendes
- Subjects
- *
SCHISTOSOMIASIS , *NANOPARTICLES , *DRUG metabolism , *CELL permeability , *URSODEOXYCHOLIC acid , *DRUG delivery systems , *HEPATOTOXICOLOGY - Abstract
Silybin (SIB) is a hepatoprotective drug known for its poor oral bioavailability, attributed to its classification as a class IV drug with significant metabolism during the first-pass effect. This study explored the potential of solid lipid nanoparticles with (SLN-SIB-U) or without (SLN-SIB) ursodeoxycholic acid and polymeric nanoparticles (PN-SIB) as delivery systems for SIB. The efficacy of these nanosystems was assessed through in vitro studies using the GRX and Caco-2 cell lines for permeability and proliferation assays, respectively, as well as in vivo experiments employing a murine model of Schistosomiasis mansoni infection in BALB/c mice. The mean diameter and encapsulation efficiency of the nanosystems were as follows: SLN-SIB (252.8 ± 4.4 nm, 90.28 ± 2.2%), SLN-SIB-U (252.9 ± 14.4 nm, 77.05 ± 2.8%), and PN-SIB (241.8 ± 4.1 nm, 98.0 ± 0.2%). In the proliferation assay with the GRX cell line, SLN-SIB and SLN-SIB-U exhibited inhibitory effects of 43.09 ± 5.74% and 38.78 ± 3.78%, respectively, compared to PN-SIB, which showed no inhibitory effect. Moreover, SLN-SIB-U demonstrated a greater apparent permeability coefficient (25.82 ± 2.2) than PN-SIB (20.76 ± 0.1), which was twice as high as that of SLN-SIB (11.32 ± 4.6) and pure SIB (11.28 ± 0.2). These findings suggest that solid lipid nanosystems hold promise for further in vivo investigations. In the murine model of acute-phase Schistosomiasis mansoni infection, both SLN-SIB and SLN-SIB-U displayed hepatoprotective effects, as evidenced by lower alanine amino transferase values (22.89 ± 1.6 and 23.93 ± 2.4 U/L, respectively) than those in control groups I (29.55 ± 0.7 U/L) and I+SIB (34.29 ± 0.3 U/L). Among the prepared nanosystems, SLN-SIB-U emerges as a promising candidate for enhancing the pharmacokinetic properties of SIB. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. 7- O -tyrosyl Silybin Derivatives as a Novel Set of Anti-Prostate Cancer Compounds.
- Author
-
Romanucci, Valeria, Pagano, Rita, Kandhari, Kushal, Zarrelli, Armando, Petrone, Maria, Agarwal, Chapla, Agarwal, Rajesh, and Di Fabio, Giovanni
- Subjects
MITSUNOBU reaction ,CELL populations ,CELL cycle ,CELL analysis ,CHEMICAL structure - Abstract
Silybin is a natural compound extensively studied for its hepatoprotective, neuroprotective and anticancer properties. Envisioning the enhancement of silybin potential by suitable modifications in its chemical structure, here, a series of new 7-O-alkyl silybins derivatives were synthesized by the Mitsunobu reaction starting from the silybins and tyrosol-based phenols, such as tyrosol (TYR, 3), 3-methoxytyrosol (MTYR, 4), and 3-hydroxytyrosol (HTYR, 5). This research sought to explore the antioxidant and anticancer properties of eighteen new derivatives and their mechanisms. In particular, the antioxidant properties of new derivatives outlined by the DPPH assay showed a very pronounced activity depending on the tyrosyl moiety (HTYR > MTYR >> TYR). A significant contribution of the HTYR moiety was observed for silybins and 2,3-dehydro-silybin-based derivatives. According to the very potent antioxidant activity, 2,3-dehydro-silybin derivatives 15ab, 15a, and 15b exerted the most potent anticancer activity in human prostate cancer PC-3 cells. Furthermore, flow cytometric analysis for cell cycle and apoptosis revealed that 15ab, 15a, and 15b induce strong G1 phase arrest and increase late apoptotic population in PC-3 cells. Additionally, Western blotting for apoptotic marker cleaved caspase-3 confirmed apoptosis induction by these silybin derivatives in PC-3 cells. These findings hold significant importance in the investigation of anticancer properties of silybin derivatives and strongly encourage swift investigation in pre-clinical models and clinical trials. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Effect of Silibinin(A) as a Potential Anti-obesity Agent
- Author
-
Juan Jose Hernández Morante, Main researcher at Eating-related disorders research unit
- Published
- 2023
14. Prospective Double Arm Randomized Trial: WBRT Alone and WBRT Plus Silibinin
- Published
- 2023
15. Silybin restores glucose uptake after tumour necrosis factor-alpha and lipopolysaccharide stimulation in 3T3-L1 adipocytes
- Author
-
Alejandra Butanda-Nuñez, Octavio Rodríguez-Cortés, Espiridión Ramos-Martínez, Marco Antonio Cerbón, Galileo Escobedo, and Anahí Chavarría
- Subjects
3T3-L1 adipocytes ,glucose uptake ,inflammatory stimuli ,LPS ,silybin ,TNFα ,Diseases of the endocrine glands. Clinical endocrinology ,RC648-665 ,Cytology ,QH573-671 ,Physiology ,QP1-981 - Abstract
Obesity is associated with a low-grade chronic inflammatory process characterized by higher circulating TNFα levels, thus contributing to insulin resistance. This study evaluated the effect of silybin, the main bioactive component of silymarin, which has anti-inflammatory properties, on TNFα levels and its impact on glucose uptake in the adipocyte cell line 3T3-L1 challenged with two different inflammatory stimuli, TNFα or lipopolysaccharide (LPS). Silybin’s pre-treatment effect was evaluated in adipocytes pre-incubated with silybin (30 or 80 µM) before challenging with the inflammatory stimuli (TNFα or LPS). For the post-treatment effect, the adipocytes were first challenged with the inflammatory stimuli and then post-treated with silybin. After treatments, TNFα production, glucose uptake, and GLUT4 protein expression were determined. Both inflammatory stimuli increased TNFα secretion, diminished GLUT4 expression, and significantly decreased glucose uptake. Silybin 30 µM only reduced TNFα secretion after the LPS challenge. Silybin 80 µM as post-treatment or pre-treatment decreased TNFα levels, improving glucose uptake. However, glucose uptake enhancement induced by silybin did not depend on GLUT4 protein expression. These results show that silybin importantly reduced TNFα levels and upregulates glucose uptake, independently of GLUT4 protein expression.
- Published
- 2024
- Full Text
- View/download PDF
16. Immunoprotective effect of silybin through blocking p53-driven caspase-9-Apaf-1-Cyt c complex formation and immune dysfunction after difenoconazole exposure in carp spleen.
- Author
-
Pan, Enzhuang, Xin, Yue, Li, Xueqing, Ping, Kaixin, Li, Xing, Sun, Ying, Xu, Xuhui, and Dong, Jingquan
- Subjects
IMMUNE complexes ,CARP ,SPLEEN ,POISONS ,NON-target organisms ,PROTEOLYTIC enzymes - Abstract
As a broad-spectrum and efficient triazole fungicide, difenoconazole is widely used, which not only pollutes the environment but also exerts toxic effects on non-target organisms. The spleen plays an important role in immune protection as an important secondary lymphoid organ in carp. In this study, we assessed the protective impact of silybin as a dietary additive on spleen tissues of carp during exposure to difenoconazole. Sixty carp were separated into four groups for this investigation including control group, difenoconazole group, silybin group, and silybin and difenoconazole group. By hematoxylin-eosin staining, dihydroethidium staining, immunohistochemical staining, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay, quantitative real-time PCR assay, Western blot analysis, biochemical assays, and immune function indicator assays, we found that silybin could prevent difenoconazole-induced spleen tissue damage, oxidative stress, and immune dysfunction, and inhibited apoptosis of carp spleen tissue cells by suppressing the formation of p53-driven caspase-9-apoptotic protease activating factor-1-cytochrome C complex. The results suggested that silybin as a dietary additive could improve spleen tissue damage and immune dysfunction induced by difenoconazole in aquaculture carp. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Silybin Alleviated Hepatic Injury by Regulating Redox Balance, Inflammatory Response, and Mitochondrial Function in Weaned Piglets under Paraquat-Induced Oxidative Stress.
- Author
-
Cai, Long, Ming, Dongxu, Chen, Wenning, Zhao, Ying, Li, Yanpin, Sun, Wenjuan, Pi, Yu, Jiang, Xianren, and Li, Xilong
- Subjects
ASPARTATE aminotransferase ,PIGLETS ,GLUTATHIONE peroxidase ,OXIDATIVE stress ,INFLAMMATION ,MITOFUSIN 2 ,OXIDANT status - Abstract
Silybin (Si) is the main element of silymarin isolated from the seeds of Silybum marianum L. Gaernt., which has superior antioxidant properties. However, the protective role of Si in maintaining liver health under oxidative stress remains ambiguous. This study aimed to investigate the underlying mechanism of the beneficial effect of dietary Si against hepatic oxidative injury induced by paraquat (PQ) in weaned piglets. A total of 24 piglets were randomly allocated to four treatments with six replicates per treatment and 1 piglet per replicate: the control group; Si group; PQ group; and Si + PQ group. Piglets in the control group and PQ group were given a basal diet, while piglets in the Si and Si + PQ groups were given a Si-supplemented diet. On the 18th day, the pigs in the PQ treatment group received an intraperitoneal injection of PQ, and the others were intraperitoneally injected with the same volume of saline. All piglets were sacrificed on day 21 for plasma and liver sample collection. The results showed that dietary Si supplementation mitigated PQ-induced liver damage, as proven by the reduction in liver pathological changes and plasma activity of alanine transaminase and aspartate transaminase. Si also improved superoxide dismutase and glutathione peroxidase activities and total antioxidant capacity, as well as decreased malondialdehyde and hydrogen peroxide concentration in the liver, which were closely related to the activation of the nuclear factor-erythroid 2-related factor 2 signaling pathway. Meanwhile, Si reduced tumor necrosis factor-α and interleukin-8 production and their transcript levels as well as abrogated the overactivation of nuclear factor-κB induced by PQ. Importantly, Si improved mitochondrial function by maintaining mitochondrial energetics and mitochondrial dynamics, which was indicated by the elevated activity of mitochondrial complexes I and V and adenosine triphosphate content, decreased expression of dynamin 1 protein, and increased expression of mitofusin 2 protein. Moreover, Si inhibited excessive hepatic apoptosis by regulating the B-cell lymphoma-2 (Bcl-2)/Bcl-2-associated-X-protein signaling pathway. Taken together, these results indicated that Si potentially mitigated PQ-induced hepatic oxidative insults by improving antioxidant capacity and mitochondrial function and inhibiting inflammation and cell apoptosis in weaned piglets. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. 高效液相色谱法测定试验鸡肉中水飞蓟宾 含量.
- Author
-
侯泽桦, 李羡钰, 孙雯可, 谢艾伶, 刘全瑞, 刘鼎阔, 于晓雪, and 李留安
- Abstract
Copyright of Food Research & Development is the property of Food Research & Development Editorial Department and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
19. Comparing different strategies to reduce hepatocellular damage in obese common marmosets (Callithrix jacchus).
- Author
-
Brown, Mallory Gwendolyn, Feller, Laine Elizabeth, Trupkiewicz, John Gregory, Hutchinson, Eric Kenneth, and Izzi, Jessica Marie
- Subjects
- *
CALLITHRIX jacchus , *ASPARTATE aminotransferase , *LIVER enzymes , *LOW-calorie diet , *OBESITY , *MILK thistle - Abstract
Background: Obesity in common marmosets (Callithrix jacchus) can lead to various liver pathologies. In other species, reduced caloric intake and weight loss improve prognosis, and, often, hepatoprotectants are used to halt or reverse hepatocellular damage from fat deposition in the liver. There are no published therapies for reducing hepatocellular damage in obese marmosets. Methods: Fifteen obese marmosets were used to evaluate the ability of caloric restriction and pharmacologic therapy (S-adenosylmethionine + milk thistle extract, or SMT), alone and combined, to reduce elevated liver enzymes. Body weight and serum chemistries were measured every 4 weeks for 6 months. Results: Across treatment groups, there was a significant reduction in liver enzymes ALT and AST over time. SMT alone significantly reduced liver enzymes ALT and AST at 6 months from baseline. Conclusions: Caloric restriction and SMT, alone and combined, are effective at reducing liver enzyme levels in obese marmosets. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Effects of silybin supplementation on growth performance, serum indexes and liver transcriptome of Peking ducks.
- Author
-
Ziyue Zhang, Bozhi Shi, Xueze Lv, Yingchao Dong, Lei Li, and Zhaofei Xia
- Subjects
DUCKS ,TRANSCRIPTOMES ,MILK thistle ,LIVER ,ANTIGEN processing - Abstract
As an emerging feed additive extracted from the traditional herb milk thistle, silybin has few applications and studies in Peking ducks. The aim of this study was to explore the practical significance of silymarin application in Peking ducks and to provide more theoretical support for the application of silymarin in livestock and poultry production. A total of 156 1-day-old healthy Peking ducks were randomly divided into four groups and supplemented with 0 mg/kg (control group), 400 mg/kg (S400), 800 mg/kg (S800) and 1,600 mg/kg (S1600) of silybin in the diets at day 14, to investigate the effects of silymarin on the growth, serum indexes and liver transcriptome of Peking ducks. The whole experiment lasted until day 42, and the sample collection was scheduled to take place in the morning. A substantial inprovement in average daily gain (ADG) and a decrease in feed conversion ratio (FCR) occurred in the S1600 group on days 14–28 compared to the control group (p < 0.05). The FCRs of other additive groups in the same period showed the same results. Supplementation of diets with silybin significantly increased serum IgA levels and when 1,600 mg/kg of silybin was given, levels of TNF-α and IL-6 were also significantly decreased (p < 0.05). In addition, we observed that the S1600 group had a significantly lower (p < 0.05) glutamine transaminase and an increased (p < 0.05) T-SOD level in the S400 group (p < 0.05). Liver transcriptome sequencing showed that 71 and 258 differentially expressed genes (DEGs) were identified in the S400 and S1600 groups, respectively, compared with the control group. DEGs related to cell composition and function, antigen processing and presentation were up-regulated, while DEGs related to insulin resistance and JAK–STAT were down-regulated. Conclusively, silybin can be used as a feed additive to improve the growth performance and health status of Peking ducks. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. 水飞蓟宾抑制 Fas/FasL 信号通路对肺结核大鼠炎症损伤及巨噬细胞凋亡的 影响.
- Author
-
王莲珊, 王家贤, and 郑成芳
- Abstract
Objective:To explore the effects of Silybin on pulmonary inflammatory injury and macrophage apoptosis in pulmonary tuberculosis (TB) rats, and its regulation on death receptor Fas and its ligand FasL. Methods: TB rat model was prepared by tail vein injection of Mycobacterium tuberculosis(Mtb). Rats were randomly separated into model group, Silybin group, Fas overexpression recombinant protein (pcDNA-Fas) group, pcDNA-Fas negative control (pcDNA-NC) group and Silybin+pcDNA-Fas group, with 15 rats in each group, and another 15 rats were selected as normal control group. Acid-fast staining was used to measure infection of lung tissue; HE staining was performed to observe pathological changes of lung tissue; expressions of TNF-α and IL-6 in lung tissue were detected by ELISA; apoptosis rate of alveolar macrophages was detected by flow cytometry combined with Annexin V-FITC/PI staining; expression levels of Fas, FasL, caspase8, caspase3 and macrophage inflammatory protein-2(MIP-2) were detected by Western blot. Results:Compared with normal control group, expressions of inflammatory factors in lung tissue and apoptotic rate of alveolar macrophages were increased in model group, Mtb infection and caseous necrosis in lung tissue were severe, and Fas/FasLmediated caspase8/3 apoptotic pathway was activated (P<0.05). Compared with model group, expressions of inflammatory factors in lung tissue and apoptosis rate of alveolar macrophages in Silybin group were reduced, Mtb infection and caseous necrosis in lung tissue were alleviated, and the activity of Fas/FasL-mediated caspase8/3 apoptosis pathway decreased (P<0.05). pcDNA-Fas was able to further activate Fas/FasL-mediated caspase8/3 apoptotic pathway, aggravate lung tissue Mtb infection and caseous necrosis, promote inflammatory damage in lung tissue and macrophage apoptosis, and weaken the anti-Fas/FasL activation, anti-inflammatory and anti-apoptotic effects of Silybin (P<0.05). Conclusion: Silybin may play an anti-Mtb infection, anti-apoptosis of lung tissue macrophages and anti-inflammatory effects by inhibiting the Fas/FasL signaling pathway. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Nanocrystal Formulation to Enhance Oral Absorption of Silybin: Preparation, In Vitro Evaluations, and Pharmacokinetic Evaluations in Rats and Healthy Human Subjects
- Author
-
SeungRee Seo, Gwan-Young Kim, Min-Hwan Kim, Kyung Won Lee, Min-Jae Kim, Mansingh Chaudhary, Khadka Bikram, Taeheon Kim, Seungmok Choi, Heejin Yang, Joo Won Park, Dae-Duk Kim, and Ki-Taek Kim
- Subjects
milk thistle ,silybin ,nanocrystal ,long-term stability ,oral bioavailability ,human pharmacokinetic ,Pharmacy and materia medica ,RS1-441 - Abstract
Despite the various therapeutic benefits and high tolerance of orally administered silybin, poor water-solubility can be the main restrictive physicochemical feature, which results in low oral bioavailability in the absorption. A milk thistle nanocrystal formulation (HM40) was prepared using a modified wet-milling method. Comprehensive characterization was performed to determine the physical morphology, crystallinity, and physicochemical properties. The long-term stability was evaluated over 24 months. In vitro silybin release was assessed at pH 1.2 for 2 h, followed by pH 6.8 for 4 h. Finally, in vivo pharmacokinetic studies were conducted in rats and healthy human volunteers. HM40 exhibited a nanocrystal structure maintaining crystallinity and enhanced the solubility and dissolution of silybin compared to that of the raw material. The stability over 24 months revealed consistent surface morphology, particle size, silybin content, and solubility. In vitro release profiles indicated a significant increase in the silybin release from HM40. In vivo pharmacokinetic studies demonstrated that HM40 showed 2.61- and 1.51-fold higher oral bioavailability in rats and humans, respectively, than that of the reference capsule. HM40 formulation presents a stable and promising approach for the oral delivery of poorly water-soluble silybin, with the potential for use in pharmaceutical formulations containing milk thistle.
- Published
- 2024
- Full Text
- View/download PDF
23. Silybin-Functionalized PCL Electrospun Fibrous Membranes for Potential Pharmaceutical and Biomedical Applications
- Author
-
Christina Spartali, Anna-Maria G. Psarra, Sotirios I. Marras, Costas Tsioptsias, Achilleas Georgantopoulos, Foteini D. Kalousi, Andreas Tsakalof, and Ioannis Tsivintzelis
- Subjects
silybin ,electrospinning ,encapsulation ,drug release ,cytocompatibility ,antioxidant activity ,Organic chemistry ,QD241-441 - Abstract
Silybin is a natural flavonolignan with potential anticancer, antioxidant, and hepatoprotective properties. In the present study, various loadings of silybin (1, 3, and 5 wt%) were encapsulated in poly-ε-caprolactone (PCL) fibers by electrospinning, in order to produce new pharmaceutical composites with improved bioactive and drug delivery properties. The morphological characteristics of the composite fibrous structures were evaluated by scanning electron microscopy (SEM), and the encapsulation efficiency and the release rate of silybin were quantified using a UV-Vis spectrophotometer. The analysis of the membranes’ thermal behavior by differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA) revealed the existence of interaction between PCL and silybin. An investigation of the cytocompatibility of the composite membranes revealed that normal cells displayed an unimpeded proliferation in the respective silybin concentrations; however, tumor cell growth demonstrated a dose-dependent inhibition. Furthermore, an effective antioxidant activity against hydrogen peroxide-induced oxidative stress in HEK-293 cells was observed for the prepared electrospun fibrous mats.
- Published
- 2024
- Full Text
- View/download PDF
24. Silibinin as a major component of milk thistle seed provides promising influences against diabetes and its complications: a systematic review
- Author
-
Zare Mehrjerdi, Parisa, Asadi, Sara, Ehsani, Elham, Askari, Vahid Reza, and Baradaran Rahimi, Vafa
- Published
- 2024
- Full Text
- View/download PDF
25. Liposomal Silybin Improves Glucose and Lipid Metabolisms in Type 2 Diabetes Mellitus Complicated with Non-Alcoholic Fatty Liver Disease via AMPK/TGF-β1/Smad Signaling.
- Author
-
Jialuo Cai, Yilin Zhu, Xiaoping Li, Guiming Deng, Yuanshan Han, Feiyun Yuan, Gangqiang Yi, and Xinhua Xia
- Abstract
Improving hepatic glucose and lipid metabolisms is an important strategy to treat type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease (T2DM-NAFLD). Silybin (SLB) has the potential hepatoprotection, while its oral bioavailability is poor. This study aims to investigate the functional role and mechanism of liposomal SLB in modulating glucose/lipid metabolism in T2DM-NAFLD. SLB was prepared by thin film dispersion method and characterized using dynamic light scattering, scanning electron microscope, high performance liquid chromatography and zeta potential analyzer. A rat model of T2DMNAFLD was used to determine the role of liposomal SLB in regulating glycolipid metabolism and hepatic damage. Rat primary hepatocytes were used to demonstrate the hepatoprotection mechanism of liposomal SLB. The encapsulation efficiency was more than 80%, which showed the average particle size of 119.76 nm. Also, the average Zeta potential was -4.76 mV. These liposomes were spherical. In rats with T2DMNAFLD, liposomal SLB alleviated insulin resistance and lipid metabolism, thereby improving hepatic lipid accumulation, inflammation and fibrosis. Besides, liposomal SLB elevated AMPK phosphorylation, and decreased collagen I/III, α-smooth muscle actin ( α-SMA), transforming growth factor-β1 (TGF-β1) and the phosphorylation of Smad2/3. In hepatocyte model, compound C partially reversed the effects of liposomal SLB on cell viability, glycolipid metabolism and AMPK/TGF-β1/Smad pathway activation. Liposomal SLB ameliorates hepatic glucose and lipid metabolisms in T2DM-NAFLD via activating AMPK/TGF-β1/Smad pathway, providing an efficient strategy for treating T2DM-NAFLD. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
26. Oral Administration of Silybin Protects Against MPTP-Induced Neurotoxicity by Reducing Pro-inflammatory Cytokines and Preserving BDNF Levels in Mice.
- Author
-
Ramírez-Carreto, Ricardo J., Zaldívar-Machorro, Víctor J., Pérez-Ramírez, Dafne J., Rodríguez-López, Blanca E., Meza, Claudia, García, Esperanza, Santamaría, Abel, and Chavarría, Anahí
- Abstract
Parkinson's disease (PD) is the second most frequent neurodegenerative disease associated with motor dysfunction secondary to the loss of dopaminergic neurons in the nigrostriatal axis. Actual therapy consists mainly of levodopa; however, its long-term use promotes secondary effects. Consequently, finding new therapeutic alternatives, such as neuroprotective molecules, is necessary. Among these alternatives is silybin (Sb), the major bioactive flavonolignan in silymarin. Both exert neuroprotective effects, preserving dopamine levels and dopaminergic neurons when administered in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse PD model, being probably Sb the potential therapeutic molecule behind this effect. To elucidate the role of Sb in the PD model, we determined the dose-dependent conservation of striatal dopamine content following Sb oral administration. Then, we evaluated motor deficit tests using the best dopamine conservative dose of Sb and determined a cytokine-dependent inflammatory profile status, malondialdehyde as an oxidative stress product, and neurotrophic factors content in the MPTP-induced mouse PD model. Our results show that oral Sb at 100 mg/kg dose conserved about 60% dopamine levels. Also, Sb improved motor deficits, preserved neurotrophic factors content and mitochondrial function, reduced lipid peroxidation, diminished proinflammatory cytokines to basal levels, enhanced fractalkine production in the striatum and substantia nigra, and increased IL-10 and IL-4 levels in the substantia nigra in the MPTP mice. Thus, oral Sb may be a potential pharmacological PD treatment alternative. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
27. The Effects of Dietary Silybin Supplementation on the Growth Performance and Regulation of Intestinal Oxidative Injury and Microflora Dysbiosis in Weaned Piglets.
- Author
-
Cai, Long, Gao, Ge, Yin, Chenggang, Bai, Rong, Li, Yanpin, Sun, Wenjuan, Pi, Yu, Jiang, Xianren, and Li, Xilong
- Subjects
DIETARY supplements ,PIGLETS ,INTESTINAL injuries ,REGULATION of growth ,DYSBIOSIS ,SWINE breeding ,FISH feeds - Abstract
Oxidative stress is the major incentive for intestinal dysfunction in weaned piglets, which usually leads to growth retardation or even death. Silybin has caught extensive attention due to its antioxidant properties. Herein, we investigated the effect of dietary silybin supplementation on growth performance and determined its protective effect on paraquat (PQ)-induced intestinal oxidative damage and microflora dysbiosis in weaned piglets. In trial 1, a total of one hundred twenty healthy weaned piglets were randomly assigned into five treatments with six replicate pens per treatment and four piglets per pen, where they were fed basal diets supplemented with silybin at 0, 50, 100, 200, or 400 mg/kg for 42 days. In trial 2, a total of 24 piglets were randomly allocated to two dietary treatments with 12 replicates per treatment and 1 piglet per pen: a basal diet or adding 400 mg/kg silybin to a basal diet. One-half piglets in each treatment were given an intraperitoneal injection of paraquat (4 mg/kg of body weight) or sterile saline on day 18. All piglets were euthanized on day 21 for sample collection. The results showed that dietary supplementation with 400 mg/kg silybin resulted in a lower feed conversion ratio, diarrhea incidence, and greater antioxidant capacity in weaned piglets. Dietary silybin enhanced intestinal antioxidant capacity and mitochondrial function in oxidative stress piglets induced by PQ. Silybin inhibited mitochondria-associated endogenous apoptotic procedures and then improved the intestinal barrier function and morphology of PQ-challenged piglets. Moreover, silybin improved intestinal microbiota dysbiosis induced by the PQ challenge by enriching short-chain fatty-acid-producing bacteria, which augmented the production of acetate and propionate. Collectively, these findings indicated that dietary silybin supplementation linearly decreased feed conversion ratio and reduced diarrhea incidence in normal conditions, and effectively alleviated oxidative stress-induced mitochondrial dysfunction, intestinal damage, and microflora dysbiosis in weaned piglets. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
28. Anti-Viral Activity of Bioactive Molecules of Silymarin against COVID-19 via In Silico Studies.
- Author
-
Zhang, Chunye, Sui, Yuxiang, Liu, Shuai, and Yang, Ming
- Subjects
- *
SILYMARIN , *GROWTH factors , *COVID-19 , *COVID-19 pandemic , *EPIDERMAL growth factor - Abstract
The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection drove the global coronavirus disease 2019 (COVID-19) pandemic, causing a huge loss of human life and a negative impact on economic development. It is an urgent necessity to explore potential drugs against viruses, such as SARS-CoV-2. Silymarin, a mixture of herb-derived polyphenolic flavonoids extracted from the milk thistle, possesses potent antioxidative, anti-apoptotic, and anti-inflammatory properties. Accumulating research studies have demonstrated the killing activity of silymarin against viruses, such as dengue virus, chikungunya virus, and hepatitis C virus. However, the anti-COVID-19 mechanisms of silymarin remain unclear. In this study, multiple disciplinary approaches and methodologies were applied to evaluate the potential mechanisms of silymarin as an anti-viral agent against SARS-CoV-2 infection. In silico approaches such as molecular docking, network pharmacology, and bioinformatic methods were incorporated to assess the ligand–protein binding properties and analyze the protein–protein interaction network. The DAVID database was used to analyze gene functions, such as the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and Gene Ontology (GO) enrichment. TCMSP and GeneCards were used to identify drug target genes and COVID-19-related genes. Our results revealed that silymarin compounds, such as silybin A/B and silymonin, displayed triplicate functions against SARS-CoV-2 infection, including directly binding with human angiotensin-converting enzyme 2 (ACE2) to inhibit SARS-CoV-2 entry into the host cells, directly binding with viral proteins RdRp and helicase to inhibit viral replication and proliferation, and regulating host immune response to indirectly inhibit viral infection. Specifically, the targets of silymarin molecules in immune regulation were screened out, such as proinflammatory cytokines TNF and IL-6 and cell growth factors VEGFA and EGF. In addition, the molecular mechanism of drug-target protein interaction was investigated, including the binding pockets of drug molecules in human ACE2 and viral proteins, the formation of hydrogen bonds, hydrophobic interactions, and other drug–protein ligand interactions. Finally, the drug-likeness results of candidate molecules passed the criteria for drug screening. Overall, this study demonstrates the molecular mechanism of silymarin molecules against SARS-CoV-2 infection. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
29. Ameliorative effects of silybin against avermectin-triggered carp spleen mitochondrial dysfunction and apoptosis through inhibition of PERK-ATF4-CHOP signaling pathway.
- Author
-
Pan, En-Zhuang, Xin, Yue, Li, Xue-Qing, Wu, Xin-Yu, Tan, Xue-Lian, and Dong, Jing-Quan
- Abstract
The aim of this study was to investigate the splenic tissue damage of environmental biological drug avermectin to freshwater cultured carp and to evaluate the effect of silybin on the splenic tissue damage of carp induced by avermectin. A total of 60 carp were divided into 4 groups with 15 carp in each group, including the control group fed with basic diet, experimental group fed with basal diet and exposed to avermectin (avermectin group), experimental group fed with basal diet supplement silybin (silybin group), and experimental group fed with basal diet supplement silybin and exposed to avermectin (silybin + avermectin group). The whole test period lasted for 30 days, and spleen tissue was collected for analysis. In this study, H&E staining, mitochondrial purification and membrane potential detection, ATP detection, DHE staining, biochemical tests, qPCR, immunohistochemistry, and apoptosis staining were used to evaluate the biological processes of spleen tissue injury, mitochondrial function, oxidative stress, apoptosis, and endoplasmic reticulum stress. The results show that silybin protected carp splenic tissue damage caused by chronic avermectin exposure, decreased mitochondrial membrane potential, decreased ATP content, ROS accumulation, oxidative stress, apoptosis, and endoplasmic reticulum stress. Silybin may ameliorate the splenic tissue damage of cultured freshwater carp caused by environmental biopesticide avermectin by alleviating mitochondrial dysfunction and inhibiting PERK-ATF4-CHOP-driven mitochondrial apoptosis. Adding silybin into the diet becomes a feasible strategy to resist the pollution of avermectin and provides a theoretical basis for creating a good living environment for freshwater carp. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
30. Intravenous Milk Thistle (Silibinin-Legalon) for Hepatic Failure Induced by Amatoxin/Amanita Mushroom Poisoning
- Published
- 2022
31. Evaluation of Silybin Nanoparticles against Liver Damage in Murine Schistosomiasis mansoni Infection
- Author
-
Daniel Figueiredo Vanzan, Ester Puna Goma, Fernanda Resende Locatelli, Thiago da Silva Honorio, Priscila de Souza Furtado, Carlos Rangel Rodrigues, Valeria Pereira de Sousa, Hilton Antônio Mata dos Santos, Flávia Almada do Carmo, Alice Simon, Alexandre dos Santos Pyrrho, António José Ribeiro, and Lucio Mendes Cabral
- Subjects
silybin ,schistosomiasis ,solid lipid nanoparticles ,polymeric nanoparticles ,polyphenolic compound ,Pharmacy and materia medica ,RS1-441 - Abstract
Silybin (SIB) is a hepatoprotective drug known for its poor oral bioavailability, attributed to its classification as a class IV drug with significant metabolism during the first-pass effect. This study explored the potential of solid lipid nanoparticles with (SLN-SIB-U) or without (SLN-SIB) ursodeoxycholic acid and polymeric nanoparticles (PN-SIB) as delivery systems for SIB. The efficacy of these nanosystems was assessed through in vitro studies using the GRX and Caco-2 cell lines for permeability and proliferation assays, respectively, as well as in vivo experiments employing a murine model of Schistosomiasis mansoni infection in BALB/c mice. The mean diameter and encapsulation efficiency of the nanosystems were as follows: SLN-SIB (252.8 ± 4.4 nm, 90.28 ± 2.2%), SLN-SIB-U (252.9 ± 14.4 nm, 77.05 ± 2.8%), and PN-SIB (241.8 ± 4.1 nm, 98.0 ± 0.2%). In the proliferation assay with the GRX cell line, SLN-SIB and SLN-SIB-U exhibited inhibitory effects of 43.09 ± 5.74% and 38.78 ± 3.78%, respectively, compared to PN-SIB, which showed no inhibitory effect. Moreover, SLN-SIB-U demonstrated a greater apparent permeability coefficient (25.82 ± 2.2) than PN-SIB (20.76 ± 0.1), which was twice as high as that of SLN-SIB (11.32 ± 4.6) and pure SIB (11.28 ± 0.2). These findings suggest that solid lipid nanosystems hold promise for further in vivo investigations. In the murine model of acute-phase Schistosomiasis mansoni infection, both SLN-SIB and SLN-SIB-U displayed hepatoprotective effects, as evidenced by lower alanine amino transferase values (22.89 ± 1.6 and 23.93 ± 2.4 U/L, respectively) than those in control groups I (29.55 ± 0.7 U/L) and I+SIB (34.29 ± 0.3 U/L). Among the prepared nanosystems, SLN-SIB-U emerges as a promising candidate for enhancing the pharmacokinetic properties of SIB.
- Published
- 2024
- Full Text
- View/download PDF
32. In vitro Assessment of the Effects of Silybin on CYP2B6-mediated Metabolism.
- Author
-
Zhang, Wenwen, Zhang, Yice, Wen, Chengming, Jiang, Xuehua, and Wang, Ling
- Subjects
- *
IN vitro studies , *DRUG-herb interactions , *OXYGENASES , *LIVER , *GENE expression , *FLAVONOLS , *DOSE-effect relationship in pharmacology , *MOLECULAR structure , *LIVER cells , *COMPUTER-assisted molecular modeling , *CHEMICAL inhibitors - Abstract
Silybin is a flavonol compound with a variety of physiological properties, such as hepatoprotective, anti-fibrogenic, and hypocholesterolemic effects. Although the in vivo and in vitro effects of silybin are frequently reported, studies on herb–drug interactions have yet to be performed. With the discovery of multiple important substrates of CYP2B6 recently, there is a growing body of evidence indicating that CYP2B6 plays a much larger role in human drug metabolism than previously thought. The purpose of this study is to determine how silybin affects the CYP2B6 enzymeʼs activity, as well as to clarify the molecular mechanisms for inhibition by silybin. The results showed that silybin inhibited CYP2B6 activity in liver microsomes in a non-competitive manner, with IC50 and Ki values of 13.9 µM and 38.4 µM, respectively. Further investigations revealed that silybin could down-regulate the expression of CYP2B6 protein in HepaRG cells. The hydrogen bond conformation of silybin in the active site of the CYP2B6 isoform was revealed by a molecular docking study. Collectively, our findings verify that silybin is an inhibitor of CYP2B6 and explain the molecular mechanism of inhibition. This can lead to a better understanding of the herb–drug interaction between silybin and the substrates of the CYP2B6 enzyme, as well as a more rational clinical use of silybin. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
33. Impact of natural antioxidant (silybin) on the thermal stability of ultra high molecular weight polyethylene: a thermogravimetric study
- Author
-
Khattar, Nidhi, Jagriti, Kainth, Shagun, Sharma, Piyush, Ahlawat, Vishal, Berar, Urmila, and Diwan, Pawan K.
- Published
- 2024
- Full Text
- View/download PDF
34. Bacterial butyrate mediates the anti-atherosclerotic effect of silybin
- Author
-
Hao-Ran Shen, Zhi-Yu Wang, Zhen Shen, Tong-Tong Liu, Yun-Dan Guo, Tian-Le Gao, Hui-Hui Guo, Yan-Xing Han, and Jian-Dong Jiang
- Subjects
Silybin ,Atherosclerosis ,Bacterial butyrate ,MCT1/4 ,Gut integrity ,Tight junction ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Silybin (SIL) is a versatile bioactive compound used for improving liver damage and lipid disorders and is also thought to be beneficial for atherosclerosis (AS). The goal of this study was to investigate the efficacy of SIL in the treatment of AS in ApoE−/−mice fed a high-fat diet and explore the mechanism underlying treatment outcomes. We found that SIL significantly alleviated AS-related parameters, including the extent of aortic plaque formation, hyperlipidemia, and adhesion molecule secretion in the vascular endothelium. 16 S rRNA gene sequencing analysis, together with the application of antibiotics, showed that intestinal butyrate-producing bacteria mediated the ameliorative effect of SIL on AS. Further analysis revealed that SIL facilitated butyrate production by increasing the level of butyryl-CoA: acetate CoA-transferase (BUT). The increased expression of monocarboxylic acid transporter-1 (MCT1) induced by butyrate and MCT4 induced by SIL in the apical and basolateral membranes of colonocytes, respectively, resulted in enhanced absorption of intestinal butyrate into the circulation, leading to the alleviation of arterial endothelium dysfunction. Moreover, the SIL-mediated increase in intestinal butyrate levels restored gut integrity by upregulating the expression of tight junction proteins and promoting gut immunity, thus inhibiting the AS-induced inflammatory response. This is the first study to show that SIL can alleviate AS by modulating the production of bacterial butyrate and its subsequent absorption.
- Published
- 2023
- Full Text
- View/download PDF
35. Antiviral and immunostimulatory effects of Ssanti-Covir, a mixed herbal formulation, in cyclophosphamide-treated mice
- Author
-
Minh-Nhut Pham, Phu-Tuong Nguyen-Dung, Thi-Kim-Nga Nguyen, Viet-Hung Tran, Nguyen-Truong-Thang Phan, Thi-Hong-Tuoi Do, Thuy-Linh Hoang, Thi-To-Uyen Nguyen, Phu-Tho Nguyen, and Huu-Thanh Nguyen
- Subjects
Andrographolide ,Immunostimulatory effect ,Plant extract ,SARS-CoV-2 ,Silybin ,Other systems of medicine ,RZ201-999 ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Background: The novel coronavirus disease 2019 (COVID-19) has raised many concerns among populations worldwide due to its high mortality and morbidity with the lack of treatment options. Many attempts to find preventive and curable approaches have been proposed to prevent infections. The consumption of herbal products or plant extracts was recommended to modulate the body's immunity and reduce the risk of diseases. Methods: In the current study, we evaluated the anti-viral effects of a mixed herbal formula, named Ssanti-Covir, which was obtained from a combination of 8 herbal species extensively employed in traditional medicine in Vietnam. The objective was to investigate the potential efficacy of Ssanti-Covir against COVID-19 infections in vero E6 cells, as well as its immunostimulatory effects on immunosuppressive mice induced by cyclophosphamide (CP). Results: The results of the study revealed that Ssanti-Covir contained significant amounts of andrographolide, silybin A, and silybin B, with concentrations of 137.08 mg/g, 72.01 mg/g, and 81.62 mg/g, respectively. Pre-incubation of Ssanti-Covir at various dilution concentrations effectively prevented cells from being infected by COVID-19, with a viral titer of 100 TCID50/0.1 ml. Oral administration of Ssanti-Covir at doses of 384 mg/kg and 576 mg/kg body weight resulted in a significant increase in the relative weight of the spleen and thymus in mice induced with CP, with p-values of
- Published
- 2023
- Full Text
- View/download PDF
36. Potential antibacterial and antioxidant inhibitory activities of Silybum marianum mediated biosynthesised He-Ne laser
- Author
-
Munirah F. Aldayel
- Subjects
Silybin ,He-Ne laser ,Antibacterial ,Disc diffusion assay ,Biology (General) ,QH301-705.5 - Abstract
A potentially beneficial method in laser irradiation is currently gaining popularity. The biosynthesis of low-power lasers has also been applied to the therapy of disease in biological tissues. This study used laser pre-treatments of Silybum marianum (S. marianum) fruit extract as a stabilising agent to bio-fabricate a low-power laser. The silybin A and silybin B of the S. marianum fruit, which are derived from seedlings before S. marianum undergoes therapy with an He-Ne laser at various intervals, were assessed for their expressive properties in this study. The findings revealed that 6-min laser pre-treatments increased silybin A + B and bacterial inhibition and improved the medicinal property of S. marianum. The analysis of the reaction records was performed using ultraviolet–visible spectroscopy. The minimum inhibitory concentration (MIC) limit for the sphere dispersion approach’s antimicrobial effect on the microorganisms under investigation was 50 to 100 g/mL. With an IC50 of 0.69 mg/mL, the laser-treated S. marianum (6 min) demonstrated radical scavenging activity. At MIC concentration, the laser-treated S. marianum (6 min) did not exhibit cytotoxicity in the MCF-7 cell line. Additionally, Salmonella typhi, methicillin-resistant Staphylococcus aureus (MRSA), and E. coli were more susceptible to the antimicrobial effects of ethanolic fruit extract with a greater silybin level. It was observed that the laser-treated S. marianum (6 min) showed beneficial antioxidant and antibacterial properties and could be employed without risk in several medical applications.
- Published
- 2023
- Full Text
- View/download PDF
37. Silibinin alleviates inflammation‐induced bone loss by modulating biological interaction between human gingival fibroblasts and monocytes.
- Author
-
Huang, Ren‐Yeong, Chang, Hua‐Yang, Chih, Shu‐Mi, Dyke, Thomas Van, Cheng, Chia‐Dan, Sung, Cheng‐En, Weng, Pei‐Wei, Shieh, Yi‐Shing, and Cheng, Wan‐Chien
- Abstract
Background: Silibinin has shown various pharmacological effects that could be attributed to its antioxidant, anti‐inflammatory, and immunoregulatory properties. However, the therapeutic potential of silibinin for periodontitis has not been investigated. Methods: The therapeutic effects of silibinin in ligation‐induced experimental periodontitis were investigated using biochemical, histological, and immunohistochemical methods. The effects of silibinin on the osteoclastogenesis of RAW264.7 cells were investigated using TRAP staining, quantitative polymerase chain reaction (qPCR), pit formation, and immunoblotting. Moreover, its effects on inflammatory cytokine production, RANKL expression, and oxidative stress in lipopolysaccharide (LPS)‐stimulated human gingival fibroblasts (HGFs) were evaluated using qPCR and flow cytometry. A coculture system was established to elucidate the effects of silibinin on the crosstalk between LPS‐stimulated HGFs and undifferentiated monocytes. Results: Silibinin significantly reduced the alveolar bone loss, decreased the gingival inflammation and RANKL expression, and decreased the RANKL/osteoprotegerin ratio in gingival tissues in experimental periodontitis. The in vitro results showed that silibinin inhibited RANKL‐induced osteoclast differentiation and function of RAW264.7 cells and suppressed RANKL‐induced nuclear factor of activated T cells 1 (NFATc1) induction and translocation through the nuclear factor‐κB and mitogen‐activated protein kinase signaling pathways. Silibinin decreased the inflammatory cytokine level and oxidative stress production in LPS‐stimulated HGFs; significantly suppressed membrane‐bound RANKL expression on LPS‐stimulated HGFs; and significantly disrupted TRAP+ cell differentiation in the coculture system. Conclusions: Silibinin effectively inhibits inflammation‐induced bone loss in experimental periodontitis based on the regulation of stimulated HGFs by inhibiting the expression of inflammatory and osteoclastogenic mediators. Collectively, targeting the inflamed HGF resolution that mediates osteogenesis may use silibinin as a potential drug‐repurposing candidate for modulating alveolar bone destruction in periodontitis. Summary: Silibinin effectively inhibits inflammation‐induced bone loss in experimental periodontitis based on the regulation of stimulated HGFs by inhibiting the expression of inflammatory and osteoclastogenic mediators. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
38. 7-O-tyrosyl Silybin Derivatives as a Novel Set of Anti-Prostate Cancer Compounds
- Author
-
Valeria Romanucci, Rita Pagano, Kushal Kandhari, Armando Zarrelli, Maria Petrone, Chapla Agarwal, Rajesh Agarwal, and Giovanni Di Fabio
- Subjects
silibinin ,silybin ,natural products ,Mitsunobu reaction ,antioxidants ,human prostate cancer ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Silybin is a natural compound extensively studied for its hepatoprotective, neuroprotective and anticancer properties. Envisioning the enhancement of silybin potential by suitable modifications in its chemical structure, here, a series of new 7-O-alkyl silybins derivatives were synthesized by the Mitsunobu reaction starting from the silybins and tyrosol-based phenols, such as tyrosol (TYR, 3), 3-methoxytyrosol (MTYR, 4), and 3-hydroxytyrosol (HTYR, 5). This research sought to explore the antioxidant and anticancer properties of eighteen new derivatives and their mechanisms. In particular, the antioxidant properties of new derivatives outlined by the DPPH assay showed a very pronounced activity depending on the tyrosyl moiety (HTYR > MTYR >> TYR). A significant contribution of the HTYR moiety was observed for silybins and 2,3-dehydro-silybin-based derivatives. According to the very potent antioxidant activity, 2,3-dehydro-silybin derivatives 15ab, 15a, and 15b exerted the most potent anticancer activity in human prostate cancer PC-3 cells. Furthermore, flow cytometric analysis for cell cycle and apoptosis revealed that 15ab, 15a, and 15b induce strong G1 phase arrest and increase late apoptotic population in PC-3 cells. Additionally, Western blotting for apoptotic marker cleaved caspase-3 confirmed apoptosis induction by these silybin derivatives in PC-3 cells. These findings hold significant importance in the investigation of anticancer properties of silybin derivatives and strongly encourage swift investigation in pre-clinical models and clinical trials.
- Published
- 2024
- Full Text
- View/download PDF
39. Silybin Alleviated Hepatic Injury by Regulating Redox Balance, Inflammatory Response, and Mitochondrial Function in Weaned Piglets under Paraquat-Induced Oxidative Stress
- Author
-
Long Cai, Dongxu Ming, Wenning Chen, Ying Zhao, Yanpin Li, Wenjuan Sun, Yu Pi, Xianren Jiang, and Xilong Li
- Subjects
silybin ,hepatic damage ,inflammation ,antioxidation ,mitochondrial function ,apoptosis ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Silybin (Si) is the main element of silymarin isolated from the seeds of Silybum marianum L. Gaernt., which has superior antioxidant properties. However, the protective role of Si in maintaining liver health under oxidative stress remains ambiguous. This study aimed to investigate the underlying mechanism of the beneficial effect of dietary Si against hepatic oxidative injury induced by paraquat (PQ) in weaned piglets. A total of 24 piglets were randomly allocated to four treatments with six replicates per treatment and 1 piglet per replicate: the control group; Si group; PQ group; and Si + PQ group. Piglets in the control group and PQ group were given a basal diet, while piglets in the Si and Si + PQ groups were given a Si-supplemented diet. On the 18th day, the pigs in the PQ treatment group received an intraperitoneal injection of PQ, and the others were intraperitoneally injected with the same volume of saline. All piglets were sacrificed on day 21 for plasma and liver sample collection. The results showed that dietary Si supplementation mitigated PQ-induced liver damage, as proven by the reduction in liver pathological changes and plasma activity of alanine transaminase and aspartate transaminase. Si also improved superoxide dismutase and glutathione peroxidase activities and total antioxidant capacity, as well as decreased malondialdehyde and hydrogen peroxide concentration in the liver, which were closely related to the activation of the nuclear factor-erythroid 2-related factor 2 signaling pathway. Meanwhile, Si reduced tumor necrosis factor-α and interleukin-8 production and their transcript levels as well as abrogated the overactivation of nuclear factor-κB induced by PQ. Importantly, Si improved mitochondrial function by maintaining mitochondrial energetics and mitochondrial dynamics, which was indicated by the elevated activity of mitochondrial complexes I and V and adenosine triphosphate content, decreased expression of dynamin 1 protein, and increased expression of mitofusin 2 protein. Moreover, Si inhibited excessive hepatic apoptosis by regulating the B-cell lymphoma-2 (Bcl-2)/Bcl-2-associated-X-protein signaling pathway. Taken together, these results indicated that Si potentially mitigated PQ-induced hepatic oxidative insults by improving antioxidant capacity and mitochondrial function and inhibiting inflammation and cell apoptosis in weaned piglets.
- Published
- 2024
- Full Text
- View/download PDF
40. Trial of Indole-3-Carbinol and Silibinin
- Published
- 2021
41. Topical treatment of tea saponin stabilized silybin nanocrystal gel reduced oxidative stress in UV-induced skin damage.
- Author
-
Gu, Huan, Liu, Xing, Chen, Ping, Shi, Mingyi, chen, Liping, and Li, Xiaofang
- Subjects
- *
XANTHAN gum , *TEA , *NATURAL products , *OXIDATIVE stress , *CELL survival , *NANOGELS - Abstract
UV-induced peroxidation is a significant factor in skin damage. Some natural products have been utilized to protect the skin. However, most of them suffer from issues such as poor bioavailability. A promising strategy is to prepare them as safe and convenient gels. In this study, we constructed Silybin Nanocrystal Gel (SIL-NG). Tea saponin, a spatial stabilizer that we have previously reported, was used to prepare SIL-NS and subsequently combined with xanthan gum to prepare SIL-NG with an excellent safety profile. This nanogel with a natural stabilizer has a suitable ductility and shows a good safety profile in vitro and in vivo. In L929 cells, SIL-NG was able to reduce H 2 O 2 -induced ROS levels. In addition, SIL-NG exhibited better antioxidant activity compared to SIL-NS. SIL-NG was able to reduce UVB irradiation-induced oxidative damage in mice, significantly increase SOD activity, and reduce MDA levels. In conclusion, our work gives a new perspective on the treatment of UV skin damage using natural ingredients. [Display omitted] • Tea saponin and xanthan gum, two natural ingredients, were used to manufacture silybin nanocrystals gel. • Silybin nanogels had no effect on L929 cell viability and were able to protect cells from peroxidative damage. • Silybin nanogels decreased oxidative stress level, and protected mouse skin from UV damage. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
42. Systematic Optimization of Solid Lipid Nanoparticles of Silybin for Improved Oral Drug Delivery by Box-Behnken Design: In Vitro and In Vivo Evaluations.
- Author
-
Nazem, Zeynab, Firoozian, Farzin, Khodabandelou, Saeideh, Mohammadi, Mojdeh, and Mahboobian, Mohammad Mehdi
- Abstract
Purpose: Silybin (SB) is the most potent flavonolignan extracted from the milk thistle plant, showing anti-oxidative properties. Owing to the lipophilic nature of SB, the oral bioavailability of SB is low. This study developed and optimized SB loaded solid lipid nanoparticles (SB-SLNs), and evaluated their in vitro and in vivo characteristics. Methods: The applied method of SLNs production was solvent emulsification and evaporation, using stearic acid as the solid lipid core and Cremophor® RH40 as the surfactant. The statistical optimization was determined using Box-Behnken design. The morphology of the optimized silybin-loaded SLNs was detected by scanning electron microscopy. Also, differential scanning calorimetry (DSC), Fourier transformation infrared spectroscopy (FTIR), and powder X-ray diffractometry (P-XRD) were used to characterize SLNs' physicochemical properties. Moreover, in vivo studies for pharmacokinetic properties of SB were performed on male Wistar rats. Results: The optimum formulation exhibited the size of 262.36 ± 12 nm, and -22.22 ± 0.87 mV of zeta potential and 74.02 ± 1.66% of entrapment efficiency. The scanning electron microscopy(SEM) images demonstrated the rough-surfaced ovate structure of SB-SLNs, and solid-state research evince the amorphous state of SB-SLNs. The in vivo evaluations showed an increased bioavailability of SLN formulation higher than pure SB in plasma. Conclusion: The significant improvement of SB-SLNs pharmacokinetic properties after single oral dose administration specified SLNs as a capable drug delivery system for SB. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
43. Investigation of Cardioprotective Activity of Silybin: Network Pharmacology, Molecular Docking, and In Vivo Studies.
- Author
-
Kumar Pasala, Praveen, Donakonda, Madhuri, Dintakurthi, Prasanth S. N. B. K., Rudrapal, Mithun, Gouru, Sampath A., and Ruksana, Kolla
- Subjects
- *
MOLECULAR docking , *PHARMACOLOGY , *MYOCARDIAL infarction , *GENE ontology , *GENE targeting , *PROTEIN-protein interactions , *BRUGADA syndrome , *POLYMER networks - Abstract
The abundant health benefits of silybin are known to benefit people with myocardial infarction (MI). However, their mechanisms of action are not precise. To address this problem, network pharmacology was used to identify the various components that can be utilized to treat this condition, and an in vivo study was conducted to evaluate the cardioprotective effect in MI rats. Genes associated with silybin and MI targets were extracted, and overlapping genes between silybin‐associated genes and MI targets were identified using Venn diagrams. Using Cytoscape, we built, visualized, and analyzed a network of compounds and genes with pathways. Protein‐protein interaction network (PPI), gene ontology (GO) function enrichment, and Kyoto Encyclopedia of Genes, and Genomes (KEGG) pathway enrichment analyses of the core targets were performed to predict its mechanism. A molecular docking study assessed the affinity between silybin and the top three genes. ECG pattern, serum CK‐MB, LDH, serum and heart tissue antioxidants, SOD and catalase in isoproterenol‐induced MI rats were used to test the cardioprotective effect of silybin. Silybin‐related genes (114) and MI‐related genes (1800) were identified, and 74 genes overlapped, in which the degrees of AKT1, TNF‐α and IL‐6 were higher than those of other targets are the disease target precisely. The enrichment of the gene set‐based indicated that the PI3K‐Akt, TNF‐α, IL‐17, VEGF, and HIF‐1 signaling pathways were significantly involved in the mechanisms of silybin against MI. The QRS complex of the ECG of silybin‐treated MI rats was restored to normal ECG and significantly increased serum (p<0.0001***) and heart tissue (p<0.0001***) SOD and serum (p<0.001**) and heart tissue (p<0.001**) catalase compared to MI rats. This study embodies the complex network relationship of multi‐target and multiple pathways of silybin in the treatment of MI and provides a novel method for further research on the mechanism of silybin. It has been suggested that silybin alleviates the symptoms of MI by improving antioxidant levels through the PI3K‐Akt/HIF‐1 pathway. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
44. Core Structure–Activity Relationship Studies of 5,7,20- O -Trimethylsilybins in Prostate Cancer Cell Models.
- Author
-
Wu, Sitong, Chen, Guanglin, Chen, Eva Y., Farshidpour, Leyla S., Zhang, Qiang, Wang, Guangdi, and Chen, Qiao-Hong
- Subjects
- *
ANDROGEN receptors , *STRUCTURE-activity relationships , *PROSTATE cancer , *CHALCONE , *CASTRATION-resistant prostate cancer , *CANCER cell proliferation , *CANCER cells - Abstract
Silibinin, also known as silybin, is isolated from milk thistle (Silybum marianum). Silibinin has been demonstrated to be a good lead compound due to its potential to prevent and treat prostate cancer. Its moderate potency and poor pharmacokinetic profile hindered it from moving forward to therapeutic use. Our research group has been working on optimizing silibinin for the potential treatment of castration-resistant prostate cancer. Our previous studies established 5,7,20-O-trimethylsilybins as promising lead compounds as they can selectively suppress androgen receptor (AR)-positive LNCaP cell proliferation. Encouraged by the promising data, the present study aims to investigate the relationships between the core structure of 5,7,20-O-trimethylsilybin and their antiproliferative activities towards AR-positive (LNCaP) and AR-negative prostate cancer cell lines (PC-3 and DU145). The structure–activity relationships among the four different core structures (including flavanonol-type flavonolignan (silibinin), flavone-type flavonolignan (hydnocarpin D), chalcone-type flavonolignan, and taxifolin (a flavonolignan precursor) indicate that 5,7,20-O-trimethylsilybins are the most promising scaffold to selectively suppress AR-positive LNCaP prostate cancer cell proliferation. Further investigation on the antiproliferative potency of their optically enriched versions of the most promising 5,7,20-O-trimethylsilybins led to the conclusion that (10R,11R) derivatives (silybin A series) are more potent than (10S,11S) derivatives (silybin B series) in suppressing AR positive LNCaP cell proliferation. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
45. Synergistic effects of silybin and curcumin on virulence and carbapenemase genes expression in multidrug resistant Klebsiella oxytoca
- Author
-
Farah H. Omer, Noor S. K. Al-Khafaji, Farah Tareq Al-Alaq, Hussein O. M. Al-Dahmoshi, Mojtaba Memariani, and Morteza Saki
- Subjects
Silybin ,Curcumin ,Antimicrobial effects ,Virulence genes ,Klebsiella oxytoca ,Medicine ,Biology (General) ,QH301-705.5 ,Science (General) ,Q1-390 - Abstract
Abstract Objective Silybin and curcumin have potential antimicrobial effects. This study aimed to evaluate the synergistic antimicrobial effects of silybin and curcumin on virulence and carbapenemase genes expression among multidrug-resistant (MDR) Klebsiella oxytoca. Results A total of 70 MDR K. oxytoca (carrying bla IMP and bla OXA-48-like genes) were included. The antibiotic susceptibility and biofilm production of isolates were determined. The silybin and curcumin at concentrations 10–500 mg/mL alone and in combination were exposed to bacterial isolates in Mueller Hinton broth medium for 24 h. The expression of bla IMP, bla OXA-48-like, mrkA, pilQ, matB and fimA genes was evaluated using quantitative real-time polymerase chain reaction (qRT-PCR). The mean minimum inhibitory concentration (MIC) of curcumin and silybin were 250 mg/mL and 500 mg/mL, respectively. The anti-virulent effect of 100 mg/mL of silybin and curcumin was shown by significant reduction in the expression of fimA (2.1-fold, P
- Published
- 2022
- Full Text
- View/download PDF
46. Silymarin Cream Versus Salicylic Acid in Treatment of Acne Vulgaris
- Author
-
Alaa Gamal Ahmed Makhlouf, Principal investigator
- Published
- 2021
47. Silybin has therapeutic efficacy against non-small cell lung cancer through targeting of Skp2
- Author
-
Shi-Bing Zhang, Ming Hong, Xiao-Yang Sun, Da Huang, Dan-Hua He, Yu-Fei Chen, Yong Yuan, and Yong-Qiang Liu
- Subjects
silybin ,nsclc ,skp2 ,p27 ,cell-cycle arrest ,Pharmacy and materia medica ,RS1-441 ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Silybin (SB), a natural flavonoid isolated from Silybum marianum, has been used to treat hepatic fibrosis in clinical settings and as a dietary supplement, because of its hepatoprotective potential. Numerous studies have shown that SB also exerts promising anticancer effects; however, the anticancer targets of SB and the underlying mechanism were unclear. Herein, we found that SB significantly inhibited the proliferation of non-small cell lung cancer without causing cytotoxicity toward normal Beas-2B bronchial epithelial cells. Mechanistically, SB binds the F-box protein Skp2 and disrupts Skp1-Skp2 interaction, thereby decreasing Skp2 protein levels, inducing accumulation of Skp2 substrates, and leading to G1-phase cell-cycle arrest and the suppression of cell migration. In lung orthotopic xenografts, SB also significantly decreased Skp2 expression and increased p27/Kip1 protein levels. SB administration inhibited tumor growth and metastasis in lung tissue, thus prolonging survival time in mice without causing obvious toxicity. Thus, SB is a potential Skp2-targeting agent that warrants further clinical investigation.
- Published
- 2022
- Full Text
- View/download PDF
48. From Medical Herb to Functional Food: Development of a Fermented Milk Containing Silybin and Protein from Milk Thistle.
- Author
-
Liu, Yanxia, Wu, Minghuo, Ren, Miaomiao, Bao, Haijun, Wang, Qing'an, Wang, Nan, Sun, Shibo, Xu, Jianqiang, Yang, Xiaojing, Zhao, Xu, Bao, Yongming, He, Gaohong, and Xu, Weiping
- Subjects
MILK thistle ,FERMENTED milk ,MILK proteins ,YOGURT ,FUNCTIONAL foods ,FERMENTED foods ,HIGH performance liquid chromatography - Abstract
Milk thistle is a traditional medicinal herb. Silybin is a medicinal component found in the seed coat of milk thistle, which has liver-protective and anti-cancer properties. Conventional studies have focused on the extraction of silybin with organic reagents, which was inapplicable to the food industry. This study aims to develop a fermented milk containing silybin and protein from the milk thistle seeds. A three step procedure was developed, comprising homogenization of milk thistle seeds, NaHCO
3 heat treatment, and microbial fermentation. The silybin was characterized by high performance liquid chromatography, and the protein was quantified and electrophorized. It was found that the homogenization step was essential for the preparation of protein, and the NaHCO3 heat treatment was the crucial step in obtaining silybin. The optimal NaHCO3 treatment settings were 1% NaHCO3 , 60°C, and 3 h, and the optimal strains for microbial fermentation were L131 (Rummeliibacillus stabekisii) and RS72 (Lactobacillus plantarum). The silybin yield in the fermented milk reached 11.24–12.14 mg/g seeds, accounting for 72.6–78.4% of the total silybin in the milk thistle seeds, and the protein yield reached 121.8–129.6 mg/g seeds. The fermented milk had a slightly sweet yoghurt-like flavor and could be used as a dietary supplement for silybin and protein. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
49. Effects of biofertilizer and vermicompost on quantitative and qualitative yield of Silybum marianum L.
- Author
-
Alipour, S.
- Abstract
To investigate the effects of vermicompost and phosphate biofertilizer Barvar-2 on quantitative and qualitative yield of Silybum marianum L., a factorial experiment was conducted in a randomized complete block design with three replications in a field near Ardebil city in 2018-2019 crop year. Vermicompost was used at five levels (0, 10, 20, 30, and 40 ton.ha
-1 ) and biofertilizer at two levels (inoculation and non-inoculation). The results showed that seed yield, 1000-seed weight, number of seeds per capitule, number of capitules per plant, biological yield, oil yield, silymarin yield, and flower fresh weight were significantly affected by different levels of vermicompost. Also, the application of phosphate biofertilizer Barvar-2 had a significant effect on all traits except inflorescence diameter. The highest amount of traits in the vermicompost treatment was obtained in the application of 40 tons.ha-1 . However, there was no statistically significant difference for the traits including number of seeds per capitule, oil, silymarin, and silybin percentage, oil yield, and number of inflorescences in the application of 40 and 30 tons vermicompost per hectare. In biofertilizer treatment, the highest amount of traits was observed in inoculation with this fertilizer. The highest silybin percentage (16.81) and silymarin yield (37.61 kg.ha-1 ) were obtained in the application of 40 tons vermicompost per hectare and the lowest one (16.12% and 30.56 kg.ha-1 , respectively) at the control level of vermicompost. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
50. Preservation of Dopamine Levels in a Mouse Model of Parkinson's Disease by Carboxymethylated Silica and Starch Nanoparticles Coupled to Silybin.
- Author
-
García, Esperanza, Arturo García‐De‐La‐Rosa, Luis, Fernanda Veloz‐Castillo, María, Ángel Méndez‐Rojas, Miguel, and Chavarría, Anahí
- Subjects
- *
SILICA nanoparticles , *PARKINSON'S disease , *LABORATORY mice , *DOPAMINE , *ANIMAL disease models , *CARBOXYMETHYL compounds , *APOMORPHINE - Abstract
Silybin has a neuroprotective effect in different models of neurodegenerative diseases as the MPTP‐induced parkinsonian model. However, silybin has poor water solubility, decreasing its efficacy when administered orally. Therefore, the search for possible vehicles or transport systems is relevant. Among the options are the drug delivery systems (DDS). In this work, we evaluated if the use of specific solvents (water or oil) or DDS [carboxymethylated silica nanoparticles (SiO2_SIL) or starch (CMS‐SIL)] would preserve the neuroprotective effect of silybin when administered orally in a Parkinson's model induced with 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP). C57BL/6J male mice were exposed to MPTP (30 mg/kg i.p) and, 30 minutes after, were treated with 100 mg/kg of silybin in oil or water as solvents or coupled to silica nanoparticles or carboxymethyl starch for five consecutive days. After the last administration of MPTP and silybin, striatal dopamine levels were determined on day seven. Our results showed that silybin in water as the non‐vehicle control had no protective effect in the MPTP model. Silybin in oil preserved 57 % dopamine levels in contrast to 72 % with SiO2_SIL and 50.7 % with CSM‐SIL. In conclusion, we demonstrated that silybin was effectively coupled to carboxymethylated silica nanoparticles and carboxymethylated starch‐based DDS without losing its neuroprotective effects. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.